GENEVA, Oct. 9 -- THALASSA BIO, INC. filed a patent application (US2026/022525) for “CONJUGATES FOR TREATMENT OF HEMOGLOBINOPATHIES AND METHODS OF USE THEREOF”. With publication no. WO/2026/213613, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....